Skip to main content

Seizure Disorders and cannabis in Tennessee

The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Listed qualifying condition
✓ Yes
LEGAL
Low-THC oil for intract…
POSSESSION
$0/yr
STATE FEE
7–30 d
TIMELINE
Listed qualifying condition. The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Tennessee statute and program

The Tennessee Low-THC Possession Authorization (intractable seizures) is the operating authority for Tennessee patient certification. The authoritative legal text is: T.C.A. § 39-17-402: Cannabis classification (Schedule VI).

What the evidence says about cannabis and Seizure Disorders

Seizure disorders comprise a broader category than epilepsy alone, encompassing conditions that produce seizures (episodes of abnormal electrical activity in the brain) including post-traumatic seizures, febrile seizures (in children), seizures associated with brain tumors or strokes, and the various epilepsy syndromes themselves.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Seizure Disorders page.

How to qualify in Tennessee

The Tennessee Low-THC Possession Authorization (intractable seizures) requires the following registration steps for a Seizure Disorders patient (or any qualifying diagnosis):

  1. Confirm intractable-seizure diagnosis with a Tennessee neurologist. Tennessee operates a narrow low-THC possession authorization under Tenn. Code Ann. §39-17-402 (the "Tennessee Cannabis Oil Law" enacted in 2015 and modestly expanded in 2021). The program covers only intractable seizure disorders. A Tennessee-licensed physician — typically a neurologist — documents the diagnosis and the determination that the patient may benefit from cannabis oil (defined as oil containing ≤0.9% THC and at least 5% CBD by weight).
  2. Obtain a physician’s written certification or order. The physician issues a signed letter or written certification that the patient has been diagnosed with intractable epilepsy and is under the physician’s care. Tennessee does not maintain a state patient registry and does not issue a state-issued medical cannabis identification card under §39-17-402.
  3. No state registration fee. Tennessee charges no state patient registration fee, because there is no state patient registry to enroll in. The patient bears only the costs of the physician evaluation and the cannabis oil product obtained from another state.
  4. Obtain low-THC cannabis oil from another state and possess as an affirmative defense. Tennessee does not authorize in-state dispensaries or cultivation under §39-17-402. The patient or parent (for a minor patient) typically obtains low-THC cannabis oil from a legal program in another state (commonly Georgia, Virginia, or Colorado). Tennessee law provides an affirmative defense against possession charges when the patient or caregiver can produce the physician’s certification. The state does not honor out-of-state medical cards for any broader cannabis use.
State registration fee
$0
Physician visit (typical)
$200–$400
Certification to card
7–30 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Tennessee registration steps, fees, and reciprocity rules, see the Tennessee cannabis-laws page.

ICD-10 code

A certifying physician documenting Seizure Disorders for the Tennessee medical cannabis program will typically record ICD-10 G40.909 or SNOMED-CT 91175000 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Tennessee list Seizure Disorders as a qualifying condition for medical cannabis?

Yes. Tennessee explicitly lists Seizure Disorders as a qualifying condition under Tennessee Low-THC Possession Authorization (intractable seizures). A patient with a documented Seizure Disorders diagnosis can pursue state-program certification with a physician registered in the state. The qualifying-condition list is set by state statute or regulation and may change. Inclusion on the list does not guarantee certification — a physician still has to evaluate the patient and decide that medical cannabis is appropriate for that specific case under Tennessee rules.

How do I get a Tennessee medical marijuana card for Seizure Disorders?

Step one is finding a physician licensed in Tennessee who is registered with Tennessee Low-THC Possession Authorization (intractable seizures) and willing to evaluate Seizure Disorders cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Tennessee does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Seizure Disorders?

For Seizure Disorders, evidence is described as strong (e.g. multiple randomized controlled trials or systematic reviews supporting effect). The mmjnow condition page for Seizure Disorders lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Seizure Disorders should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Seizure Disorders and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Seizure Disorders; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. T.C.A. § 39-17-402: Cannabis classification (Schedule VI)accessed May 15, 2026
  2. SB 280 (2015): Low-THC cannabis oil possession authorizationaccessed May 15, 2026
  3. NORML: Tennessee Lawsaccessed May 15, 2026
  4. Wikipedia: Cannabis in Tennesseeaccessed May 15, 2026
  5. T.C.A. §39-17-418: Simple possession or casual exchange (penalty schedule)accessed May 17, 2026
  6. Tennessee Department of Agriculture: Industrial Hemp Programaccessed May 17, 2026
  7. Tennessee General Assembly bill trackeraccessed May 17, 2026
  8. Nashville/Davidson County District Attorney: small-amount possession discretion policyaccessed May 17, 2026
  9. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 15, 2026
  10. FDA: Epidiolex (cannabidiol) approval labelaccessed May 15, 2026
  11. NIH National Institute of Neurological Disorders and Stroke: Epilepsies and Seizuresaccessed May 15, 2026